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Abstract 
 
Neutrophils are often exclusively considered as first line innate immune defence, able to rapidly 
kill or trap pathogens and causing in case of over activation tissue damage. In the female 
reproductive tract, however, the presence and activity of neutrophils seem to be tightly 
regulated. Major players in orchestrating this regulation are cyclical steroid sex hormones 
present during the menstrual cycle and pregnancy. This review describes the role of sex 
hormones in regulating directly or indirectly the functionality of neutrophils, the role of 
neutrophils during fertilisation and pregnancy and in controlling viral, fungal and bacterial 
infection. This review also discusses the consequence of overt neutrophil activation in 
pregnancy pathologies.  
 
1. Introduction 
 
Polymorphonuclear neutrophils (PMN) are a vital component of the innate immune system’s 
rapid response team [1-4].  They are characterized by a multi-lobed nucleus, granular cytoplasm 
and short life span. In humans they are particularly numerous, accounting for approximately 
70% of circulating leucocytes, while in mice their number is much lower, being of the order of 
3% [1-4].   
PMN are highly specialized immune effector cells, possessing a diverse number of weapons in 
their armoury with which they can neutralize or eliminate pathogens [2,5]. These include 
phagocytosis, the production of reactive oxygen species (ROS), release of potent bactericidal 
enzymes by degranulation, and the formation of neutrophil extracellular traps (NETs) [2,5]. The 
latter are generated by the extrusion of DNA strands into the extracellular milieu, where they 
can ensnare invasive pathogens [5,6].  The presence of lytic enzymes such as neutrophil elastase 
(NE) or myeloperoxidase (MPO) on NETs enhances their antimicrobial activity [5,6]. NETosis 
may involve neutrophil demise (lytic NETosis), or entail their survival (vital NETosis) [7-9]. The 
signalling cascade invoked during NETosis includes production of ROS (reactive oxygen species) 
by NADPH oxidase, the nuclear translocation of NE and MPO, and histone deamination by PAD4 
(peptidyl arginine deiminase 4) [10-12].  Recently a novel form of NETosis termed ApoNETosis 
was discovered [13].  This unique form, triggered by UV irradiation, involves concomitant 
apoptosis and NETosis[13].   
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PMN potentially contribute to various stages of the reproductive process by assisting with 
conception and implantation, ensuring fetal wellbeing during pregnancy and finally contributing 
to parturition and post-partum maternal health (reviewed in [14,15]). On the other hand, 
aberrant PMN activity has been noted in severe pregnancy related disorders such as 
preeclampsia (PE) [16,17], recurrent fetal loss (RFL) [18] or gestational diabetes mellitus 
(GDM) [19]. These data suggest that altered or overt PMN activity may play a role in the 
underlying aetiology of these disorders. 
Our intention in this review is to highlight new observations made during discrete stages of the 
reproductive cycle, focussing particularly the role of sex hormones and cytokines in modulating 
neutrophil activity and their potential dysregulation in pathology.  
 
2. Hormone regulation of the reproductive cycle – introducing the players and setting 
the stage 
 
The steroid sex hormones play a crucial role in optimizing the milieu of the female reproductive 
tract (FRT) to ensure conception, implantation, maintenance and growth of the fetus throughout 
gestation [20-23]. Estrogen exists in a number of forms, including estrone (E1), 17-2-estradiol 
(E2), estriol (E3) and estetriol (E4) [20-23]. In reproductively active humans the major form is 
E2, whilst in pregnancy E3 is the predominant form, being largely produced by the placenta. E4 
is unique by being produced by the fetal liver. Like E2, Progesterone (P4) is present in both 
sexes albeit it much higher in females where it increases post-puberty and diminishes post-
menopause. P4 is also produced by the placenta during pregnancy. Akin to E3, the 
concentrations of P4 increase from the beginning of the second trimester, peaking immediately 
prior to parturition [20-23]. 
An interesting interplay occurs in the menstrual cycle between E2 and P4, in that E2 levels peak 
in the follicular phase prior to ovulation, whilst P4 concentrations are greatest in the luteal 
phase where it would assist with implantation of a fertilized zygote [20-23]. 
In the estrous cycle of mammalian therian females, estrogen produced by the mature follicules 
initiates the phase of sexual receptivity (estrus), whereas P4 production either assists with the 
progression of gestation or a period of inactivity (anestrus) [24]. 
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A vast array of peptide hormones, many of which are produced by the placenta, contribute to 
the completion of a successful pregnancy, including human placental lactogen (hPL), calcitonin, 
activins and inhibins, placenta growth factor (PGF) or leptin. While an essential function of 
these hormones is to regulate maternal metabolism in order to promote fetal growth, or alter 
the ability of fetal trophoblast cells to invade maternal tissue, several of these factors have been 
shown to possess additional immune modulatory capacity [25,26].  Of particular interest in this 
discourse is human chorionic gonadotropin (hCG) and vaso-active intestinal peptide (VIP) [27]. 
hCG is produced by the syncytiotrophoblast, the single layer of contiguous fetal tissue directly in 
contact with the maternal circulation, while VIP is produced by the underlying cytotrophoblast 
tissue [27]. As is discussed below, both exhibit the ability to modify PMN behaviour during 
pregnancy. 
 
3.   Hormones regulate neutrophil infiltration of the female reproductive tract  
 
The process whereby circulatory PMN migrate to sites of infection in the female reproductive 
tract is currently unclear, but it would appear that cyclical steroid sex hormones levels play an 
important role in this process [20,28-31]. Several years ago Tibbetts et al showed that P4 given 
concurrently with estrogen to ovariectomized mice for 4 days antagonises the ability of 
estrogen to recruit macrophages and neutrophils into the mouse uterus and this effect was 
dependent on progesterone receptors [32].  
That the hormonal regulation of PMN influx into the female reproductive tract mucosal tissues 
can go awry is evident from the predisposition of women to fungal vaginal infections with 
opportunistic pathogens such as C. albicans [30,31].  Vulvovaginal candidiasis is frequently 
observed during pregnancy, or in the luteal phase of the menstrual cycle, as well as upon 
prolonged treatment with E2 [30,31].   
A recent study addressed the underlying mechanism leading to this enhanced susceptibility, 
using a translational murine model for candida infection [31]. In this model system Salinas-
Munoz and colleagues noted that vaginal application of E2, which predisposes such mice to 
infection with C. albicans, lead to a retention of PMN in the vaginal tissue, while application of P4 
permitted their trans-epithelial migration into the vaginal lumen [31].  An examination of the 
female reproductive tract histology indicated that PMN accumulation was greatest in the lower 
female reproductive tract (fornix and ectocervix) in E2 than in mock or P4 treated mice. They 
furthermore determined that the failure of PMN to traverse the epithelial cell barrier in E2 
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treated mice was not due to a decrease in either MMP9, the enzyme required for degradation of 
the basement membrane, or the integrins (CD18/CD11b) required for docking to epithelial cells 
[31].  Rather, it appeared that epithelial factors required to initiate trans-epithelial migration 
were down regulated by E2 treatment interacting with the estrogen receptor alpha ESR1. Upon 
this interaction  they observed that expression of CD47, an important PMN docking molecule 
and CD44v6, a molecule which facilitates PMN release into the lumen were decreased by E2 
treatment. This effect of E2 appears to be restricted to FRT epithelium, as no similar 
observation was noted concerning the expression of these molecules in gut epithelia upon 
application of E2 [31]. 
A noteworthy observation made during this study was that when PMN remained attached to the 
epithelium following E2 treatment, they were incapable of neutralizing pathogens such as C. 
albicans, whereas those unattached in the FRT lumen, following P4 treatment, displayed a 
robust candida-cidal activity. It thus appears that during the estrous cycle, E2 will favour sperm 
survival and fertilization, by retaining PMN in an inactive epithelium associated state. Upon 
successful zygote formation, P4 alters this status, allowing the trans-epithelial migration of the 
PMN into the mucosal lumen, where they are able to combat pathogenic infections, in order to 
protect the pregnancy (Figure 1) [31]. 
These data were underscored by a further recent study documenting the importance of E2 in 
maintaining the integrity of the vaginal epithelium and regulating PMN flux across this cell 
barrier [29]. In this study the estrogen receptor (ESR1) was conditionally ablated in the murine 
vaginal epithelium. In such animals, lack of an estrogen response was determined to render the 
vaginal tissue highly susceptible to laceration during mating. This was determined to result 
from diminished keratin expression and lack of a cornified protective layer [29].   
Furthermore, excessive PMN infiltration of the vaginal tissue, readily detectable in vaginal 
smears, was noted in these mice regardless of the stage of the estrous cycle. These PMN 
exhibited enhanced expression of MMP9, the enzyme required for trans-epithelial migration. 
ESR1 ablated mice also exhibited reduced levels of bacterial infiltration compared to wild type 
animals [29].    
In summary, these data, hence, provide new insight into the mechanism rendering women 
sensitive to vaginosis during phases of pregnancy, menstruation or following hormone 
replacement therapy. They also offer an explanation for the variation in PMN populations due to 
oscillations in E2 and P4 levels during the menstrual cycle. They furthermore reiterate the 
importance of E2 in maintaining the integrity of epithelial mucosal tissue. 
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An unanswered question is whether long-term application of progesterone used to prevent 
preterm delivery [21,33,34], reduces the susceptibility of such pregnant women to vaginosis.   
 
4. NETs in the vaginal mucosa tackle viruses 
 
PMN are a crucial component of mucosal immunity, where they dispose of invasive pathogens 
by phagocytosis or degranulation [28]. A novel aspect is the ability of PMN located in the FRT 
lumen to employ NETs in order to ensnare and kill invasive pathogens; a process that even 
appears to apply to viruses, such as HIV (human immunodeficiency virus) [35]. 
Several previous reports have indicated that viral infections can trigger NETosis by PMN 
attracted to the site of infection, a process which can have severe clinical consequences, for 
instance in pulmonary infections [36-40]. 
Direct evidence that NETs could trap HIV virions was obtained by Saitoh and colleagues [41], 
using a technique termed super-resolution structured illumination microscopy (SR-SIM), which 
permits a greater degree of resolution than conventional fluorescence microscopy (200 nm).  
In an initial exploratory investigation, circulatory PMN obtained from healthy donors were 
stimulated by phorbol ester to trigger the NETotic cascade, following which they were co-
cultured with HIV-1 virions. An examination of the NETs in these cultures by SR-SIM ultra-high 
definition microscopy, as well as scanning electron microscopy (SEM), clearly indicated that 
individual HIV-1 virions were trapped by the sticky DNA lattice structures. They further 
determined that HIV-1 virions trapped by NETs were incapacitated by the presence of PMN 
proteins (MPO and -defensin), known to coat NETs. Subsequent analyses indicated that HIV-1 
virions were to be capable of activating isolated PMN directly and triggering NETs formation in 
a process involving toll-like receptors (TLR) 7 and 8 [41]. Since HIV-1 induced NETs lead to 
reduced infection of co-cultured CD4+ T cells, it is plausible that NETosis may play an important 
initial role in combatting viral infection [39]. 
Recent data suggests that the interaction between PMN and HIV-1 virions is not restricted to the 
circulation but may involve PMN in the FRT mucosa [35].  In their examination Barr and 
colleagues observed that when challenged with HIV-1 viral-like particles, PMN isolated from 
FRT smears rapidly formed NETs that entrapped and incapacitated the virions [35].  Of interest 
is that viral particle induced NETosis occurred by ROS independent means [35].   
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While these data are encouraging, there appear to be several caveats concerning the interaction 
of HIV-1 and PMN, the most striking of which may be the report made by   
Bowers and colleagues, which indicated that HIV-1 may exploit its interaction with circulatory 
PMN to down-regulate the host’s immune response [42]. In this study it was determined that 
HIV-1 induced expression of PD-L1 (programmed cell death protein ligand 1) on circulatory 
PMN [42]. PMN isolated from HIV-1 infected individuals were shown to suppress T cell function 
by a mechanism involving PD-L1/PD-1 interaction and ROS generation [42]. 
In the context of the above findings, it would be worthwhile clarifying whether the use of 
injected contraceptives associated with a moderate increased risk for HIV-1 infection in high 
risk populations [43,44], may be due to altered PMN behaviour in the FRT. 
 
5.   Neutrophils in the female reproductive tract – interaction with semen 
 
The process of insemination involves the deposition of millions of sperm into the female 
reproductive tract, after which an intriguing interplay between the female reproductive tract 
and semen ensues, whereby the progress of the most motile sperm towards the receptive ovum 
is promoted, while the passage of any co-deposited pathogens is hindered [15,45,46]. In 
addition, excess sperm are removed in order to prevent antigenic exposure in the recipient 
female, failure of which can lead to infertility.  On the other hand, the presence of PMN has to be 
regulated in such a manner to ensure sufficient sperm survival for fertilization [15]. As 
discusses above, for this reason PMN may be absent from the vaginal lumen during the 
ovulatory phase; a feature which may render this tissue susceptible to infection. 
Previous studies have indicated that species-specific differences exist between bovine and 
equine PMN concerning their interaction with spermatozoa during fertilization [45,46].  In this 
regard, equine PMN strongly interacted with spermatozoa, rapidly forming NETs upon exposure 
to equine semen [45,46]. This action is countered by the presence of a factor with DNAse I like 
activity in equine seminal plasma. This factor was shown to disrupt semen induced NETs, but 
not those triggered by E. coli. On the other hand, while bovine spermatozoa were recognized 
and phagocytosed by PMN, this interaction was determined to depend on the presence of 
seminal plasma, as sperm cleared of seminal plasma were determined to be relatively 
impervious to PMN action.  This difference between the two species may reflect upon the modes 
A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved. 
of semen deposition. In the equine system the sperm are deposited directly in the uterus, and as 
such there is a tight limit wherein the maternal immune system can interact with the ejaculum.  
In the bovine system, the ejaculate is deposited in the vagina, and the sperm need to traverse a 
lengthy distance in order to reach the ovum. It appears that additional mechanisms to that of 
seminal plasma are operative to ensure safe passage of the sperm as they traverse the female 
reproductive tract [45-49].  In this context, in vitro experiments have indicated that the ability 
of PMN to phagocytose sperm, or generate NETs is down-modulated by bovine oviduct fluid, of 
which Alpha 1-acid glycoprotein appears to be regulatory factor [47,48].  
Although these and other reports would suggest that inappropriate interactions between sperm 
and PMN could contribute to infertility, only one study has examined this aspect in humans [50].  
In their report, Zambrano and colleagues co-incubated isolated human PMN with fresh human 
sperm [50]. This interaction was determined to trigger the generation of NETs in a time and 
concentration dependent manner.  Since sperm motility was impeded by NETs formation, they 
concluded that should such an interaction occur on a large scale in the human female 
reproductive tract, that this would reduce the chance of successful fertilization (Figure 1) [50]. 
Unfortunately no clear data currently exist suggesting that human infertility could be attributed 
to unwarranted interaction in the female reproductive tract between PMN and semen. 
 
6.  The influence of pregnancy on the pro-NETotic behaviour of circulatory neutrophils: 
interplay between progesterone, estrogen and G-CSF 
 
Since pregnancy is associated with a subliminal activation of circulatory PMN, evident by 
increased ROS production and expression of activation markers (CD11b) [51], we recently 
examined what the NETotic response was during the course of normal healthy pregnancies [52].  
Our study confirmed that during pregnancy circulatory PMN displayed an increased activation 
status, and an increased propensity for degranulation and phagocytosis. We also observed that 
such PMN exhibited an enhanced tendency to form NETs, which increased throughout gestation, 
peaking at term [52].  The regulation of this pro-NETotic state was determined to be of a multi-
modal nature involving an interaction between G-CSF (granulocyte colony stimulating factor) 
and steroid sex hormones [52].    
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It was noted that G-CSF, which increased progressively during gestation, leading to a boost in 
circulatory PMN numbers, lead to a generalized pro-NETotic state.  In the 1st trimester of 
pregnancy, NETosis was additionally enhanced by the activity of hCG, a peptide hormone 
produced by the placenta after implantation.   
During the remaining period of gestation till term a complex interaction between G-CSF, E2/E3 
and P4 was noted in that the estrogen molecules exhibited a pronounced pro-NETotic influence. 
This could in part be to the increased expression of PAD4, as this gene bears an estrogen 
response element, since these cells displayed extensive histone citrullination, a key part of the 
NETotic cascade [12]. 
The action of E2/E3 was strongly antagonized by the action of progesterone, in that the PMN 
were not able to progress down the NETotic pathway. This restraint appeared to be due to an 
inability of neutrophil elastase (NE) to migrate into the nucleus [52], where it would cleave 
histone molecules, another vital step required for fulminant NETs extrusion (Figure 2) [53]. 
It would thus appear that this sophisticated and complex regulation serves to retain  
circulatory PMN in a high state of alert, ready to attack invasive pathogens. NETs formation 
would, however, only be triggered if appropriately challenged. Since aberrant NETosis can lead 
to damage of surrounding tissues, this complex hormonally regulated safeguard could assist in 
ensuring optimal safety of mother and unborn child.  
 
7.  Overt PMN activation is associated with excessive NETosis in PE 
 
PE is a severe life-threatening disorder of late pregnancy, characterized by sudden elevation in 
blood pressure and oedema in previously normotensive pregnant women [54-57]. PE is a 
leading cause of fetal and maternal mortality, and has a pronounced influence on post-partum 
health of both parties. PE is a complex disorder with a multi-facetted aetiology, having at least 
two separate forms based on gestational age at onset of symptoms:  early onset PE (eoPE: < 34 
weeks) and late onset PE (loPE: > 34 weeks) [55,56]. In general eoPE poses the greater clinical 
threat in that the maternal symptoms are more severe and the fetus is frequently growth 
restricted [56]. Although most cases with PE are with the late onset form (≈90%), these can still 
be associated with poor outcome, especially if occurring in tertiary healthcare centres [58]. 
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Placental malfunction is proposed to play a key role in the underlying aetiology of eoPE [57]. 
This is characterized by a defect in trophoblast differentiation and subsequent inadequate 
modification of the maternal spiral arteries, resulting in an inadequate supply of maternal blood 
to the fetal compartment of the placenta [57].  Starved of nutrients and oxygen, the 
syncytiotrophoblast reacts by the excessive shedding of highly inflammatory microparticles into 
the maternal circulation [59]. These particles have been proposed to contribute to key features 
of PE such as endothelial cell damage or inappropriate activation of maternal immune cells, 
including induction of NETs [17,60]. An overt maternal inflammatory response appears to be 
crucial for the development of loPE, with risk factors including diabetes prior to conception, 
gestational diabetes mellitus (GDM), super-obesity or even air pollution [61].  
In an extension of their analysis of PMN activity in normal pregnancy, the Oxford research group 
of Redman and Sargent observed that circulatory PMN were excessively activated in cases with 
manifest PE [51]. A striking finding aspect of this analysis was that PMN in cases PE were 
determined to be more highly activated that in cases with sepsis, used a positive control for a 
highly inflammatory disorder [51].  It furthermore appeared that this activation was triggered 
by the excessive release of highly pro-inflammatory micro-debris by the placenta, a feature 
known to occur in PE [62]. 
A major research focus in our laboratory at the time of these reports was the examination of 
cell-free nucleic acids in maternal blood as a means for non-invasive prenatal diagnosis [63].  
During the course of these investigations we had observed that manifest PE was associated with 
a significant elevation in the concentration of both placentally and maternally-derived cell free 
DNA (cfDNA) [64].  As such we were very intrigued by the then novel report that PMN can 
extrude their genomic DNA into the extracellular environment in the form of NETs [6], and 
posed the query whether these could be the source of increased maternal cfDNA in PE [65]. 
To our surprise we observed that PMN isolated from normal healthy individuals readily formed 
NETs in vitro upon treatment with placental microparticles of the type used by the Oxford 
group in their investigations [17]. Since placental microparticles are released in increased 
amounts by the syncytiotrophoblast into the maternal circulation in PE, we examined pertinent 
placental tissue-sections by fluorescent immunohistochemistry, where a vast presence of PMN 
NETs structures was detected directly in the intervillous space of affected placentae [17]. 
To address whether the overt presence of NETs in PE could contribute to placental dysfunction, 
we made use of a translational murine model in collaboration with the research groups of 
Wagner and Karumanchi in Boston [66]. This murine model relies on an imbalance of 
angiogenic factors, notably sFlt-1 (soluble fms-like tyrosine kinase 1) which has been noted in 
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PE [67]. By antagonizing the action of VEGF (vascular endothelial growth factor), the excessive 
production of sFlt-1 by the placenta in PE, leads to widespread endothelial damage [67].   
In this murine model, over expression of sFlt-1 was shown to lead to a massive influx of PMN 
and occurrence of NETs in the placentae; a feature associated with reduced litter size and fetal 
demise [66].  In mice incapable of undergoing NETosis due to genetic ablation of the PAD4 
enzyme, an amelioration of the effect of excessive sFlt-1 expression was noted [66]. Although 
not completely analogous to the situation observed in human pregnancies affected by PE, these 
data do indicate that aberrant NETs formation can contribute to placental dysfunction and 
potentially ensuing fetal loss. Is currently not known and matter of research if PMNs response 
could be causative of the pathological pregnancies or just consequence of the altered placental 
environment. 
 
8. Infiltrating PMN alter placental function in GDM via the action of exogenous NE 
 
During our examination of PMN activity in normal pregnancy we noted an extremely high level 
of NETosis in one sample [19]. Consultation of the case history indicated that this pregnant 
woman had been diagnosed with GDM at the time of blood sampling [19]. GDM is a unique form 
of glucose intolerance, being of a transient nature and only occurring during pregnancy in 
women with no prior history of diabetes [68-70]. GDM shares a number of features in common 
with T2DM, such as a systemic inflammation associated with the metabolic syndrome. Like 
T2DM, GDM occurs with greater frequency in obese individuals [71]. Accordingly GDM may be 
viewed as a momentary unmasking of a T2DM-like condition facilitated by pregnancy. GDM 
does not contain an autoimmune component like T1DM. Pregnancies affected by GDM are at an 
increased risk of developing PE, while post-partum both mother and offspring are at an 
increased susceptibility of developing T2DM [72]. 
Our analysis of 9 cases with GDM verified that NETosis was indeed exceptionally high in such 
individuals and that PMN isolated from such cases displayed pronounced activation and 
spontaneous generation of NETs by isolated neutrophils in in vitro culture [19]. The latter was 
determined to be due to the presence of increased concentrations of TNFin the circulation of 
pregnant women with GDM, resulting from the placenta as it struggles to cope with altered 
glucose levels, particularly hyperglycaemia [19,73].   
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TNF is known to have pronounced influence on PMN priming, rending them highly susceptible 
to secondary stimuli [74]. In addition, hyperglycaemic conditions were determined to also 
promote PMN activation [75]. It is therefore possible that these two factors may act in consort 
to drive excessive PMN activation in GDM [19,76].  
Akin to what we had observed in PE, extensive PMN infiltrates could be detected in GDM 
placentae.  These infiltrates could result from TNF production by the trophoblast, since this 
cytokine has pronounced chemokine activity. The degree of NETosis was, however, not as 
pronounced as in PE.  Instead highly prodigious liberation of NE into the extracellular 
environment surrounding the infiltrates was noted [19]. Analogous to what had been observed 
in PMN infiltrates into tumours [77], exogenous NE was taken up by surrounding cells, where 
key signal transducing components were incapacitated by action of this potent enzyme [19].   In 
our case we noted the enzymatic degradation of IRS1 and GLUT4, resulting in altered response 
to insulin and glucose by the affected trophoblast tissue [19].   
It is currently unclear if these PMN induced changes in trophoblast signalling and metabolism 
result in the enhanced deportation of syncytiotrophoblast-derived microparticles. Such an event 
could play a key role promoting the inflammatory cascade underlying the development of PE.  
Although it is clear that a myriad factors contribute to the increased occurrence of PE in GDM 
pregnancies, it is plausible that altered PMN activity could provide a causal link between these 
two pathologies (for an extensive discussion refer to [76]). 
 
9. Could a hormone imbalance contribute to the development of pregnancy related 
pathologies such as PE? 
 
Since steroid sex hormones modulate PMN activity in pregnancy, the question arises whether an 
imbalance in these factors could contribute to PMN dysregulation in PE or other pregnancy-
related complications.  Although there is no direct proof that such a mechanism may be 
operative, there are a number of lines pointing in this direction. 
The first being that estrogens promote placental angiogenesis by enhancing VEGF gene 
expression and uterine artery vasodilation by increasing NO production, key events ensuring a 
healthy pregnancy outcome [23].  A further primary line of evidence was provided by the 
detection of reduced COMT (catechol-O-methyltransferase) enzyme activity in PE placentae, and 
that mice lacking this enzyme exhibit PE-like symptoms [23].    
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Since COMT plays an important role in estrogen metabolism, Jobe and colleagues performed 
detailed analysis using mass spectrometry of estrogen subtypes and metabolic derivatives in 
cases with PE, which were stratified into severe PE (sPE) and moderate PE (mPE) [78]. They 
determined that all three common forms of estrogen (E1, E2 and E3) were reduced in the 
plasma of sPE cases with when compared to sPE cases or matching normal healthy pregnancies.  
In contrast cases with sPE exhibited significantly higher levels of 16 keto-172-estradiol (16E2), 
than mPE cases or matching healthy controls. This keto variant appears to be an intermediary 
form between E2 and E3, being derived from E2 by the action of cytochrome P450. The function 
of this variant molecule is not clear. As we observed that both E2 and E3 enhanced PMN 
activation, promoting a pro-NETotic phenotype, it is possible that highly elevated levels of this 
intermediary form could significantly alter PMN activity. 
Significant differences in products of hydroxylation, O-methylation or epimerization were also 
noted, indicating that the metabolism of steroid hormones is dramatically altered in PE, 
especially in cases with sPE [78]. Although the PE cases in this study were stratified into 
moderate or severe, they were all loPE forms. It is thus open to speculation how much more 
extensive the changes in steroid metabolism would be in eoPE cases, which characteristically 
have more severe clinical symptoms. 
Recently a more extensive analysis of steroid sex hormone levels in pregnancies affected by PE 
(N=86) and matching healthy controls (N=97), was performed by Wu and colleagues [22]. This 
analysis indicated that both E2 and P4 levels were significantly reduced in PE when compared 
to healthy controls. These reduced levels of E2 and P4 appeared to be due to a lower production 
by the placenta, as the levels synthesized by placenta explant in-vitro cultures were lower in 
tissues obtained from cases with PE than when using healthy control samples. Of interest is that 
no significant difference could be discerned between cases with eoPE (N=35) and loPE (N=51) 
regardless of severity [22]. A further striking observation was that no significant difference was 
apparent in either E2 or P4 levels in pregnancies with PE bearing growth retarded fetuses. Thus 
these data reinforce the notion that an imbalance in sex hormone levels can contribute to the 
development of PE,  yet do not provide evidence that this involves some form of placental 
dysfunction. If this were the case, then it would be expected that this hormone imbalance would 
be more pronounced in cases with eoPE or exhibiting fetal growth restriction, events clearly 
associated with placental anomalies. Since low E2/P4 levels are associated with both eoPE and 
loPE cases, it would appear that the influence of reduced hormone levels is more distal and 
systemic than local to the placenta. It could thus be that this hormone imbalance leads to an 
altered modulation of the maternal immune system, a feature which appears to be common to 
both early and late forms of PE [61]. 
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It should, however, be noted that other factors such as life style can influence circulating steroid 
hormone levels [79]. In this regard it was noted that obesity is associated with reduced P4 
levels, which may influence fetal birth weight [79].  Although the study by Diemert and 
colleagues was too small (N=200) to provide any details regarding the incidence of PE in their 
study cohort, it is noteworthy that obesity has emerged as an important risk factor for the 
development of loPE, but not eoPE [80]. Furthermore, obesity contributes to the development of 
GDM, itself a pronounced risk factor for PE [71].  Since PMN activity is altered in GDM and may 
play a role in the subsequent development of PE [76], it may worthwhile examining the 
relationship between BMI and E2/P4 levels in this context. 
  
10. VIP – potent new kid on the block 
 
Originally described as a neuropeptide, VIP (vasoactive intestinal peptide) has emerged as a 
very interesting regulatory factor at the feto-maternal interface [27,81]. In human pregnancy, 
VIP is expressed by the syncytiotrophoblast directly at the site of feto-maternal interaction, 
highly suggestive of a crucial role in regulating the maternal immune response [81]. In the 
context of this review, it is noteworthy that its expression is regulated by P4.  
By the use of in vitro co-culture systems between a trophoblast cell line (Swan 71 cells) and 
PBMCs (peripheral blood mononuclear cells) it was shown that VIP triggered an increase in 
Fox3p regulatory T cells [82]. VIP also lead to an increase in the expression of 
immunosuppressive cytokines, such as IL-10, associated with a Th2 phenotype known to favour 
pregnancy.    
Initial evidence that VIP induced an immunosuppressive state at the feto-maternal interface and 
that this had a pronounced effect on pregnancy outcome was obtained in translational rodent 
model systems [83].  In mice expression of VIP was detected mid-gestation at the sites of 
implantation (days 9-11). In these studies use was made of NOD (non-obese diabetic) mice, 
prone to autoimmune complications including the development of IDDM (insulin dependent 
diabetes mellitus). These mice have poor pregnancy outcome, leading to fetal demise and 
resorption.  This may be due to limited vascular remodelling, or from aberrant immune 
interactions at the feto-maternal interface, or a combination of both.  Tissues were removed 
from both vital and failed implantation sites of pregnant NOD mice; VIP expression was largely 
detected on trophoblast giant cells in the former, while its expression was significantly reduced 
in the latter. In vitro treatment of these tissue biopsies with exogenous VIP lead to the increased 
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expression of regulatory cytokines such as IL-10 and TGF, associated with a Th2 
immunosuppressive phenotype. An increase in the expression of Foxp3 was also noted, 
indicative of an increased presence of regulatory T cells with immunosuppressive function. In 
contrast, in failed sites of implantation, a decrease in an immunosuppressive milieu was noted 
with a concomitant increase in IL-17, a potent pro-inflammatory cytokine. Treatment of 
pregnant NOD mice at day 6.5 of pregnancy resulted in improved pregnancy outcome, 
accompanied by an increase in IL-10, TGF, and Foxp3.  These data, hence, clearly suggest that 
VIP is able to promote pregnancy outcome by modulating the maternal immune system and 
inducing an immunosuppressive state favouring implantation and fetal survival [83]. 
That VIP can influence PMN behaviour and possibly regulate NETosis was the subject of a recent 
report by Calo and colleagues [81]. In this study use was made of 1st trimester trophoblast cell 
lines (Swan-71 and HTR8) in combination with PMN isolated from healthy donor blood 
samples. It was noted that treatment of isolated PMN with either conditioned medium form 
trophoblast cultures or exogenous VIP reduced their NETotic response to phorbol ester. This 
was found to correlate with a decrease in ROS production in treated PMN. This effect was 
deemed specific for VIP as it could be reversed by the addition of a VIP receptor antagonist, and 
was not evident in culture medium from trophoblast cells in which expression of the VIP had 
been silenced. An interesting aspect of this report was that VIP enhanced PMN apoptosis, 
especially by reducing the anti-apoptotic effect of LPS, and promoting their clearance by 
monocytes [81]. 
Although these data are truly novel and exciting, it remains to see what role, if any, VIP plays in 
the development of complex disorders such as PE, and whether its application has any 
therapeutic merit. 
 
11. Pregnancy, NETs and thrombosis 
 
Pregnant women face an increased risk (4 to 5 fold) for venous thrombosis [84], which is 
further dramatically increased by the presence of PE [85].  Evidence also suggest that the risk of 
venous thrombotic embolism is greatest immediately post-partum [84]. 
In normal pregnancy, it has been suggested that increased venous thrombotic embolism is the 
result of a state of hyper-coagulation existing during pregnancy, a mechanism used to protect 
women from blood loss during childbirth [84].  It is not clear what the underlying cause for 
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increased venous thrombotic embolism in PE is. However, the observation that NETs promote 
coagulation and thereby contribute to blood clot formation may shed new light onto this enigma 
[86].  
The initial observation was made in the laboratory of Denisa Wagner in Boston, where it was 
noted that when NETs were perfused with blood, this lead to platelet adhesion, activation and 
aggregation [86].  The disruption of NETs by the addition of DNAse, or the addition of heparin, 
prevented clot formation [86].  This report was followed up by a series of elegant studies in 
mice prone to coagulopathies, where it was noted that NETs induced thrombi were reneged by 
genetic ablation of the PAD4 gene [87,88]. 
The mechanism whereby NETs promote coagulation is currently not clear at all, but may involve 
interaction with platelets [89]. In this context it has been observed that NETs can trigger 
platelet activation, and that activated platelets can in turn promote NETosis [89,90]. If left 
unchecked, this could provide the basis for autocatalytic loop with potentially disastrous 
consequences. It furthermore seems that intact NETs may not be required, but rather that 
isolated NETs components such as cell-free DNA, histones or liberated serine proteases may 
provide the crucial impetus [90,91].  
It may, therefore, be that our own observations indicating that PE is associated with increased 
concentrations of circulatory cfDNA as well as liberated NE, may provide vital clues concerning 
the increased incidence of venous thrombotic embolism in cases with PE [64,92,93].  Additional 
credence for such a supposition is provided by observations made in a collaborative study with 
Redman and Sargent in Oxford [94]. In this study it was noted that the concentrations of 
maternal cfDNA were greatest during labour and immediately post-partum, and that these were 
significantly greater in cases with severe PE.  Should these factors indeed contribute to 
enhanced coagulation, then our data would fit well with the increased incidence of venous 
thrombotic embolism under such conditions [93]. 
 
12. The use of surrogate markers to assess NETotic activity – a word of caution  
The implication of aberrant NETosis in a wide variety of disorders has led to a veritable boom in 
the number of analyses addressing this issue. Unfortunately the quantitation of NETs is not 
simple, relying on the isolation of PMN from blood samples, their in vitro stimulation and 
detection [95,96]. Furthermore, the presence of NETs needs to be verified in order to ensure 
that the correct structures are being examined and not some artefact [97]. 
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As these procedures are fraught with difficulty, prone to operator error and not amenable to 
routine clinical practise, the need has been voiced for alternatives. Since we and others have 
previously observed that pathologies such as PE or rheumatoid arthritis are associated with 
increased levels of cfDNA, and that these elevations may correlate with enhanced neutrophil 
NETosis, it is enticing to use cfDNA as a surrogate marker for NETs formation [17,65,98,99].  
 Accordingly many researchers have turned to the analysis of cfDNA or histone/DNA complexes 
as surrogate markers for NETs, since the quantity of these can be readily determined using qRT-
PCR, fluorescent DNA binding dyes or appropriate ELISA assays [98,99].  
While this practise is widely used, it has to be used with a degree of caution, since it is not clear 
what the source of cfDNA in the sample being examined is. In order to confirm that cfDNA is 
indeed of NETotic origin, it is necessary to  use immunoassays which detect complexes of cfDNA 
associated with NET components such as MPO [98,99].  A further alternative is by the detection 
of citrullinated histone molecules in the cfDNA fraction, since histone citrullination is a 
prerequisite for the NETotic process [100]. In this manner, the presence of these cfDNA 
complexes serves to indicate that this material is derived from NETosis and not from apotosis or 
other forms of cell death. Unfortunately the accuracy of these alternate assays has not been 
explored in large scale studies.  
Another concern is the indiscriminate use of plasma or serum for sample collection and 
analysis, a practise that can lead to vastly different results, as a small perusal of the extensive 
literature concerning the use for cfDNA for non-invasive prenatal diagnosis or cancer 
monitoring will reveal [101]. In brief, these collective data indicate that cfDNA molecules in 
rapidly processed plasma samples are indicative of the steady state evident in the circulation at 
the time of blood sampling. By the use of transplant recipients, both solid organ and 
hemopoeitic stem cells, it was shown that the vast proportion of this material was of 
hemopoeitic origin, probably resulting from the enucleation of erythroblasts as they mature to 
anuclear erythrocytes [101]. 
Amongst this material, traces could be accounted for by organs such as kidneys, increases of 
which were suggestive of transplant failure or rejection [102]. It was furthermore shown that 
cfDNA in the circulation has an extremely short half-life, being of the order of 15 minutes, 
indicating that the pool of cfDNA is constantly being replenished.  
In serum, the quantity of cfDNA is much higher due to the demise of blood cells during the 
clotting procedure. In this instance it appears that the levels of cfDNA may be higher under 
conditions where PMN exhibit an increased pro-NETotic tendency, such as rheumatoid arthritis, 
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pregnancy or PE [98,99].  This was evident in the increased proportion of nuclear material 
complexed to cytoplasmic granular components such as MPO or NE. This facet was, however, 
best observed in serum samples permitted to coagulate normally at room temperature without 
the presence of accelerators. 
 
 13. Summary and conclusions 
 
In this review we have attempted to provide an overview of the diverse actions carried out by 
PMN in ensuring successful reproduction and species propagation.  The initiation of this process 
starts in the FRT where PMN serve to remove excess spermatozoa and engage with pathogens 
including viruses, thereby rendering an optimal environment for implantation of the fertilized 
zygote. The sex hormones, E2 and P4 play a key role in this process by regulating the tightness 
of epithelial junctions, thereby controlling trans-epithelial migration. 
During pregnancy PMN activity and NET forming ability is tightly controlled in an almost ying-
yang like manner, whereby P4 counteracts the pro-NETotic influence of E2 and G-CSF. The 
skewing of this process in GDM by TNF and hyperglycaemia may contribute to the 
development PE.  The presence of a pro-NETotic state in pregnancy and its deregulation in PE 
may provide the basis for the increased incidence of VTE in affected pregnant women. 
The observation that VIP may hinder or reduce NETosis opens up the avenue for new biological 
therapeutics, a long awaited and much needed development in obstetrics [103]. 
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Figure Legend 
Figure 1: Cyclic steroid sex hormones regulate the permeability of the FRT tract allowing 
neutrophils to access the FRT but exclusively during the post ovulatory phase and in pregnancy 
where progesterone is high. In contrast, to permit the survival of sperm and their mobility, 
oestrogen decrease the membrane permeability decreasing the migration of neutrophils to the 
FRT. This can result in increased risk of infection. 
Figure 2: Progesterone controls the NETotic process in neutrophils blocking the translocation of 
neutrophils elastase to the nucleus where it is required for histone cleavage. 
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